APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Infectious Substance Packaging

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Infectious Substance Packaging Industry Growth and Trends Forecast to 2032

Report ID 173941990125 December 2025106 pages

Choose your research edition.

Industry ResearchInfectious Substance Packaging Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Substance Packaging Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Infectious Substance Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Substance Packaging Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Substance Packaging Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Infectious Substance Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Infectious Substance Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Infectious Substance Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infectious Substance Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Infectious Substance Packaging include Air Sea Containers, CIBESMED Ltd, ALEX BREUER GMBH, E3 Cortex, Berlin Packaging LLC, CFT Canada, ICC, Therapak™ and Serpac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Infectious Substance Packaging market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Infectious Substance Packaging market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Infectious Substance Packaging market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Infectious Substance Packaging.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Infectious Substance Packaging market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Infectious Substance Packaging Market by Company

Air Sea Containers

CIBESMED Ltd

ALEX BREUER GMBH

E3 Cortex

Berlin Packaging LLC

CFT Canada

ICC

Therapak™

Serpac

Friobox

Infectious Substance Packaging Segment by Type

UN2814

UN2900

UN3373

Others

Infectious Substance Packaging Segment by Application

Healthcare and Medical Laboratories

Pharmaceutical Industry

Veterinary Medicine

Hazardous Waste Management

Infectious Substance Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Substance Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Substance Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Substance Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Infectious Substance Packaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Infectious Substance Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of UN2814 Table 2. Major Company of UN2900 Table 3. Major Company of UN3373 Table 4. Major Company of Others Table 5. Global Infectious Substance Packaging Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Infectious Substance Packaging Sales by Type (2021-2026) & (k units) Table 7. Global Infectious Substance Packaging Sales Market Share in Volume by Type (2021-2026) Table 8. Global Infectious Substance Packaging Sales by Type (2021-2026) & (US$ Million) Table 9. Global Infectious Substance Packaging Sales Market Share in Value by Type (2021-2026) Table 10. Global Infectious Substance Packaging Price by Type (2021-2026) & (USD/unit) Table 11. Global Infectious Substance Packaging Sales by Type (2027-2032) & (k units) Table 12. Global Infectious Substance Packaging Sales Market Share in Volume by Type (2027-2032) Table 13. Global Infectious Substance Packaging Sales by Type (2027-2032) & (US$ Million) Table 14. Global Infectious Substance Packaging Sales Market Share in Value by Type (2027-2032) Table 15. Global Infectious Substance Packaging Price by Type (2027-2032) & (USD/unit) Table 16. North America Infectious Substance Packaging Sales by Type (2021-2026) & (k units) Table 17. North America Infectious Substance Packaging Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Infectious Substance Packaging Sales by Type (2021-2026) & (k units) Table 19. Europe Infectious Substance Packaging Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Infectious Substance Packaging Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Infectious Substance Packaging Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Infectious Substance Packaging Sales by Type (2021-2026) & (k units) Table 23. Latin America Infectious Substance Packaging Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Infectious Substance Packaging Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Infectious Substance Packaging Sales by Type (2021-2026) & (US$ Million) Table 26. Infectious Substance Packaging Industry Trends Table 27. Infectious Substance Packaging Industry Drivers Table 28. Infectious Substance Packaging Industry Opportunities and Challenges Table 29. Infectious Substance Packaging Industry Restraints Table 30. Global Infectious Substance Packaging Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Infectious Substance Packaging Revenue Market Share by Company (2021-2026) Table 32. Global Infectious Substance Packaging Sales by Company (2021-2026) & (k units) Table 33. Global Infectious Substance Packaging Sales Share by Company (2021-2026) Table 34. Global Infectious Substance Packaging Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Infectious Substance Packaging Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Infectious Substance Packaging Major Company Production Sites and Headquarters Table 37. Global Infectious Substance Packaging Company, Product Type & Application Table 38. Global Infectious Substance Packaging Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Infectious Substance Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Infectious Substance Packaging Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Infectious Substance Packaging Sales by Region (2021-2026) & (k units) Table 43. Global Infectious Substance Packaging Sales Market Share in Volume by Region (2021-2026) Table 44. Global Infectious Substance Packaging Sales by Region (2021-2026) & (US$ Million) Table 45. Global Infectious Substance Packaging Sales Market Share in Value by Region (2021-2026) Table 46. Global Infectious Substance Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Infectious Substance Packaging Sales by Region (2027-2032) & (k units) Table 48. Global Infectious Substance Packaging Sales Market Share in Volume by Region (2027-2032) Table 49. Global Infectious Substance Packaging Sales by Region (2027-2032) & (US$ Million) Table 50. Global Infectious Substance Packaging Sales Market Share in Value by Region (2027-2032) Table 51. Global Infectious Substance Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Infectious Substance Packaging Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Infectious Substance Packaging Sales by Application (2021-2026) & (k units) Table 54. Global Infectious Substance Packaging Sales Market Share in Volume by Application (2021-2026) Table 55. Global Infectious Substance Packaging Sales by Application (2021-2026) & (US$ Million) Table 56. Global Infectious Substance Packaging Sales Market Share in Value by Application (2021-2026) Table 57. Global Infectious Substance Packaging Price by Application (2021-2026) & (USD/unit) Table 58. Global Infectious Substance Packaging Sales by Application (2027-2032) & (k units) Table 59. Global Infectious Substance Packaging Sales Market Share in Volume by Application (2027-2032) Table 60. Global Infectious Substance Packaging Sales by Application (2027-2032) & (US$ Million) Table 61. Global Infectious Substance Packaging Sales Market Share in Value by Application (2027-2032) Table 62. Global Infectious Substance Packaging Price by Application (2027-2032) & (USD/unit) Table 63. North America Infectious Substance Packaging Sales by Application (2021-2026) & (k units) Table 64. North America Infectious Substance Packaging Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Infectious Substance Packaging Sales by Application (2021-2026) & (k units) Table 66. Europe Infectious Substance Packaging Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Infectious Substance Packaging Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Infectious Substance Packaging Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Infectious Substance Packaging Sales by Application (2021-2026) & (k units) Table 70. Latin America Infectious Substance Packaging Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Infectious Substance Packaging Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Infectious Substance Packaging Sales by Application (2021-2026) & (US$ Million) Table 73. Air Sea Containers Company Information Table 74. Air Sea Containers Business Overview Table 75. Air Sea Containers Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Air Sea Containers Infectious Substance Packaging Product Portfolio Table 77. Air Sea Containers Recent Development Table 78. CIBESMED Ltd Company Information Table 79. CIBESMED Ltd Business Overview Table 80. CIBESMED Ltd Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. CIBESMED Ltd Infectious Substance Packaging Product Portfolio Table 82. CIBESMED Ltd Recent Development Table 83. ALEX BREUER GMBH Company Information Table 84. ALEX BREUER GMBH Business Overview Table 85. ALEX BREUER GMBH Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. ALEX BREUER GMBH Infectious Substance Packaging Product Portfolio Table 87. ALEX BREUER GMBH Recent Development Table 88. E3 Cortex Company Information Table 89. E3 Cortex Business Overview Table 90. E3 Cortex Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. E3 Cortex Infectious Substance Packaging Product Portfolio Table 92. E3 Cortex Recent Development Table 93. Berlin Packaging LLC Company Information Table 94. Berlin Packaging LLC Business Overview Table 95. Berlin Packaging LLC Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Berlin Packaging LLC Infectious Substance Packaging Product Portfolio Table 97. Berlin Packaging LLC Recent Development Table 98. CFT Canada Company Information Table 99. CFT Canada Business Overview Table 100. CFT Canada Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. CFT Canada Infectious Substance Packaging Product Portfolio Table 102. CFT Canada Recent Development Table 103. ICC Company Information Table 104. ICC Business Overview Table 105. ICC Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ICC Infectious Substance Packaging Product Portfolio Table 107. ICC Recent Development Table 108. Therapak™ Company Information Table 109. Therapak™ Business Overview Table 110. Therapak™ Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Therapak™ Infectious Substance Packaging Product Portfolio Table 112. Therapak™ Recent Development Table 113. Serpac Company Information Table 114. Serpac Business Overview Table 115. Serpac Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Serpac Infectious Substance Packaging Product Portfolio Table 117. Serpac Recent Development Table 118. Friobox Company Information Table 119. Friobox Business Overview Table 120. Friobox Infectious Substance Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Friobox Infectious Substance Packaging Product Portfolio Table 122. Friobox Recent Development Table 123. North America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. North America Infectious Substance Packaging Sales by Country (2021-2026) & (k units) Table 125. North America Infectious Substance Packaging Sales Market Share by Country (2021-2026) Table 126. North America Infectious Substance Packaging Sales Forecast by Country (2027-2032) & (k units) Table 127. North America Infectious Substance Packaging Sales Market Share Forecast by Country (2027-2032) Table 128. North America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Infectious Substance Packaging Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Infectious Substance Packaging Market Share by Country (2021-2026) Table 131. North America Infectious Substance Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Infectious Substance Packaging Market Share Forecast by Country (2027-2032) Table 133. Europe Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Europe Infectious Substance Packaging Sales by Country (2021-2026) & (k units) Table 135. Europe Infectious Substance Packaging Sales Market Share by Country (2021-2026) Table 136. Europe Infectious Substance Packaging Sales Forecast by Country (2027-2032) & (k units) Table 137. Europe Infectious Substance Packaging Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Infectious Substance Packaging Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Infectious Substance Packaging Market Share by Country (2021-2026) Table 141. Europe Infectious Substance Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Infectious Substance Packaging Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Infectious Substance Packaging Sales by Country (2021-2026) & (k units) Table 145. Asia-Pacific Infectious Substance Packaging Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Infectious Substance Packaging Sales Forecast by Country (2027-2032) & (k units) Table 147. Asia-Pacific Infectious Substance Packaging Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Infectious Substance Packaging Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Infectious Substance Packaging Market Share by Country (2021-2026) Table 151. Asia-Pacific Infectious Substance Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Infectious Substance Packaging Market Share Forecast by Country (2027-2032) Table 153. Latin America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Latin America Infectious Substance Packaging Sales by Country (2021-2026) & (k units) Table 155. Latin America Infectious Substance Packaging Sales Market Share by Country (2021-2026) Table 156. Latin America Infectious Substance Packaging Sales Forecast by Country (2027-2032) & (k units) Table 157. Latin America Infectious Substance Packaging Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Infectious Substance Packaging Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Infectious Substance Packaging Market Share by Country (2021-2026) Table 161. Latin America Infectious Substance Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Infectious Substance Packaging Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Infectious Substance Packaging Sales by Country (2021-2026) & (k units) Table 165. Middle East and Africa Infectious Substance Packaging Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Infectious Substance Packaging Sales Forecast by Country (2027-2032) & (k units) Table 167. Middle East and Africa Infectious Substance Packaging Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Infectious Substance Packaging Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Infectious Substance Packaging Market Share by Country (2021-2026) Table 171. Middle East and Africa Infectious Substance Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Infectious Substance Packaging Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Infectious Substance Packaging Distributors List Table 176. Infectious Substance Packaging Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Infectious Substance Packaging Image Figure 2. Global Infectious Substance Packaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infectious Substance Packaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Infectious Substance Packaging Sales (2021-2032) & (k units) Figure 5. UN2814 Image Figure 6. Global UN2814 Sales YoY Growth (2021-2032) & (k units) Figure 7. UN2900 Image Figure 8. Global UN2900 Sales YoY Growth (2021-2032) & (k units) Figure 9. UN3373 Image Figure 10. Global UN3373 Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Infectious Substance Packaging Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Infectious Substance Packaging Market Share by Type 2025 VS 2032 Figure 15. North America Infectious Substance Packaging Sales Market Share in Volume by Type in 2025 Figure 16. North America Infectious Substance Packaging Sales Market Share in Value by Type in 2025 Figure 17. Europe Infectious Substance Packaging Sales Market Share in Volume by Type in 2025 Figure 18. Europe Infectious Substance Packaging Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Infectious Substance Packaging Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Infectious Substance Packaging Sales Market Share in Value by Type in 2025 Figure 21. Latin America Infectious Substance Packaging Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Infectious Substance Packaging Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Infectious Substance Packaging Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Infectious Substance Packaging Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Infectious Substance Packaging Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Healthcare and Medical Laboratories Image Figure 28. Global Healthcare and Medical Laboratories Sales YoY Growth (2021-2032) & (k units) Figure 29. Pharmaceutical Industry Image Figure 30. Global Pharmaceutical Industry Sales YoY Growth (2021-2032) & (k units) Figure 31. Veterinary Medicine Image Figure 32. Global Veterinary Medicine Sales YoY Growth (2021-2032) & (k units) Figure 33. Hazardous Waste Management Image Figure 34. Global Hazardous Waste Management Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Infectious Substance Packaging Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Infectious Substance Packaging Market Share by Application 2025 VS 2032 Figure 37. North America Infectious Substance Packaging Sales Market Share in Volume by Application in 2025 Figure 38. North America Infectious Substance Packaging Sales Market Share in Value by Application in 2025 Figure 39. Europe Infectious Substance Packaging Sales Market Share in Volume by Application in 2025 Figure 40. Europe Infectious Substance Packaging Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Infectious Substance Packaging Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Infectious Substance Packaging Sales Market Share in Value by Application in 2025 Figure 43. Latin America Infectious Substance Packaging Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Infectious Substance Packaging Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Infectious Substance Packaging Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Infectious Substance Packaging Sales Market Share in Value by Application in 2025 Figure 47. North America Infectious Substance Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Infectious Substance Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Infectious Substance Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Infectious Substance Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Infectious Substance Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Infectious Substance Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Infectious Substance Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Infectious Substance Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Infectious Substance Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Infectious Substance Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Infectious Substance Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Infectious Substance Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Infectious Substance Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Infectious Substance Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Infectious Substance Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Infectious Substance Packaging Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Infectious Substance Packaging Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • UN2814
  • UN2900
  • UN3373
  • Others
Applications
  • Healthcare and Medical Laboratories
  • Pharmaceutical Industry
  • Veterinary Medicine
  • Hazardous Waste Management
Companies covered
  • Air Sea Containers
  • CIBESMED Ltd
  • ALEX BREUER GMBH
  • E3 Cortex
  • Berlin Packaging LLC
  • CFT Canada
  • ICC
  • Therapak™
  • Serpac
  • Friobox

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Infectious Substance Packaging Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Infectious Substance Packaging Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Infectious Substance Packaging Market by Type
  6. 1.3.1 UN2814
  7. 1.3.2 UN2900
  8. 1.3.3 UN3373
  9. 1.3.4 Others
  10. 1.4 Global Infectious Substance Packaging Market Size by Type
  11. 1.4.1 Global Infectious Substance Packaging Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Infectious Substance Packaging Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Infectious Substance Packaging Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Infectious Substance Packaging Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Infectious Substance Packaging Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Infectious Substance Packaging Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Infectious Substance Packaging Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Infectious Substance Packaging Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Infectious Substance Packaging Industry Trends
  2. 2.2 Infectious Substance Packaging Industry Drivers
  3. 2.3 Infectious Substance Packaging Industry Opportunities and Challenges
  4. 2.4 Infectious Substance Packaging Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Infectious Substance Packaging Revenue (2021-2026)
  2. 3.2 Global Top Players by Infectious Substance Packaging Sales (2021-2026)
  3. 3.3 Global Top Players by Infectious Substance Packaging Price (2021-2026)
  4. 3.4 Global Infectious Substance Packaging Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Infectious Substance Packaging Major Company Production Sites & Headquarters
  6. 3.6 Global Infectious Substance Packaging Company, Product Type & Application
  7. 3.7 Global Infectious Substance Packaging Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Infectious Substance Packaging Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Infectious Substance Packaging Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Infectious Substance Packaging Tier 1, Tier 2, and Tier 3
4 Infectious Substance Packaging Regional Status and Outlook
  1. 4.1 Global Infectious Substance Packaging Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Infectious Substance Packaging Historic Market Size by Region
  3. 4.2.1 Global Infectious Substance Packaging Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Infectious Substance Packaging Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Infectious Substance Packaging Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Infectious Substance Packaging Forecasted Market Size by Region
  7. 4.3.1 Global Infectious Substance Packaging Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Infectious Substance Packaging Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Infectious Substance Packaging Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Infectious Substance Packaging by Application
  1. 5.1 Infectious Substance Packaging Market by Application
  2. 5.1.1 Healthcare and Medical Laboratories
  3. 5.1.2 Pharmaceutical Industry
  4. 5.1.3 Veterinary Medicine
  5. 5.1.4 Hazardous Waste Management
  6. 5.2 Global Infectious Substance Packaging Market Size by Application
  7. 5.2.1 Global Infectious Substance Packaging Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Infectious Substance Packaging Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Infectious Substance Packaging Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Infectious Substance Packaging Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Infectious Substance Packaging Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Infectious Substance Packaging Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Infectious Substance Packaging Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Infectious Substance Packaging Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Air Sea Containers
  2. 6.1.1 Air Sea Containers Company Information
  3. 6.1.2 Air Sea Containers Business Overview
  4. 6.1.3 Air Sea Containers Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Air Sea Containers Infectious Substance Packaging Product Portfolio
  6. 6.1.5 Air Sea Containers Recent Developments
  7. 6.2 CIBESMED Ltd
  8. 6.2.1 CIBESMED Ltd Company Information
  9. 6.2.2 CIBESMED Ltd Business Overview
  10. 6.2.3 CIBESMED Ltd Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CIBESMED Ltd Infectious Substance Packaging Product Portfolio
  12. 6.2.5 CIBESMED Ltd Recent Developments
  13. 6.3 ALEX BREUER GMBH
  14. 6.3.1 ALEX BREUER GMBH Company Information
  15. 6.3.2 ALEX BREUER GMBH Business Overview
  16. 6.3.3 ALEX BREUER GMBH Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ALEX BREUER GMBH Infectious Substance Packaging Product Portfolio
  18. 6.3.5 ALEX BREUER GMBH Recent Developments
  19. 6.4 E3 Cortex
  20. 6.4.1 E3 Cortex Company Information
  21. 6.4.2 E3 Cortex Business Overview
  22. 6.4.3 E3 Cortex Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 E3 Cortex Infectious Substance Packaging Product Portfolio
  24. 6.4.5 E3 Cortex Recent Developments
  25. 6.5 Berlin Packaging LLC
  26. 6.5.1 Berlin Packaging LLC Company Information
  27. 6.5.2 Berlin Packaging LLC Business Overview
  28. 6.5.3 Berlin Packaging LLC Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Berlin Packaging LLC Infectious Substance Packaging Product Portfolio
  30. 6.5.5 Berlin Packaging LLC Recent Developments
  31. 6.6 CFT Canada
  32. 6.6.1 CFT Canada Company Information
  33. 6.6.2 CFT Canada Business Overview
  34. 6.6.3 CFT Canada Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CFT Canada Infectious Substance Packaging Product Portfolio
  36. 6.6.5 CFT Canada Recent Developments
  37. 6.7 ICC
  38. 6.7.1 ICC Company Information
  39. 6.7.2 ICC Business Overview
  40. 6.7.3 ICC Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ICC Infectious Substance Packaging Product Portfolio
  42. 6.7.5 ICC Recent Developments
  43. 6.8 Therapak™
  44. 6.8.1 Therapak™ Company Information
  45. 6.8.2 Therapak™ Business Overview
  46. 6.8.3 Therapak™ Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Therapak™ Infectious Substance Packaging Product Portfolio
  48. 6.8.5 Therapak™ Recent Developments
  49. 6.9 Serpac
  50. 6.9.1 Serpac Company Information
  51. 6.9.2 Serpac Business Overview
  52. 6.9.3 Serpac Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Serpac Infectious Substance Packaging Product Portfolio
  54. 6.9.5 Serpac Recent Developments
  55. 6.10 Friobox
  56. 6.10.1 Friobox Company Information
  57. 6.10.2 Friobox Business Overview
  58. 6.10.3 Friobox Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Friobox Infectious Substance Packaging Product Portfolio
  60. 6.10.5 Friobox Recent Developments
7 North America by Country
  1. 7.1 North America Infectious Substance Packaging Sales by Country
  2. 7.1.1 North America Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Infectious Substance Packaging Sales by Country (2021-2026)
  4. 7.1.3 North America Infectious Substance Packaging Sales Forecast by Country (2027-2032)
  5. 7.2 North America Infectious Substance Packaging Market Size by Country
  6. 7.2.1 North America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Infectious Substance Packaging Market Size by Country (2021-2026)
  8. 7.2.3 North America Infectious Substance Packaging Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Infectious Substance Packaging Sales by Country
  2. 8.1.1 Europe Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Infectious Substance Packaging Sales by Country (2021-2026)
  4. 8.1.3 Europe Infectious Substance Packaging Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Infectious Substance Packaging Market Size by Country
  6. 8.2.1 Europe Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Infectious Substance Packaging Market Size by Country (2021-2026)
  8. 8.2.3 Europe Infectious Substance Packaging Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Infectious Substance Packaging Sales by Country
  2. 9.1.1 Asia-Pacific Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Infectious Substance Packaging Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Infectious Substance Packaging Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Infectious Substance Packaging Market Size by Country
  6. 9.2.1 Asia-Pacific Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Infectious Substance Packaging Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Infectious Substance Packaging Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Infectious Substance Packaging Sales by Country
  2. 10.1.1 South America Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Infectious Substance Packaging Sales by Country (2021-2026)
  4. 10.1.3 South America Infectious Substance Packaging Sales Forecast by Country (2027-2032)
  5. 10.2 South America Infectious Substance Packaging Market Size by Country
  6. 10.2.1 South America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Infectious Substance Packaging Market Size by Country (2021-2026)
  8. 10.2.3 South America Infectious Substance Packaging Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Infectious Substance Packaging Sales by Country
  2. 11.1.1 Middle East and Africa Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Infectious Substance Packaging Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Infectious Substance Packaging Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Infectious Substance Packaging Market Size by Country
  6. 11.2.1 Middle East and Africa Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Infectious Substance Packaging Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Infectious Substance Packaging Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Infectious Substance Packaging Value Chain Analysis
  2. 12.1.1 Infectious Substance Packaging Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Infectious Substance Packaging Production Mode & Process
  7. 12.2 Infectious Substance Packaging Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Infectious Substance Packaging Distributors
  10. 12.2.3 Infectious Substance Packaging Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst